Home > Products

Products

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC65883 3,5-Dichloro-6-iodopyrazolo[1,5-a]pyrimidine Featured
DC65884 CCR2-RA Featured
DC65885 Stilbamidine dihydrochloride Featured Stilbamidine dihydrochloride is a blocker of neuromuscular transmission and axonal conduction. It is used to study the distribution of the drug in the organs and tissues of rats following intravenous injection.
DC65886 MCU-i11 Featured MCU-i11 is a novel negative modulator of the MCU, binding MICU1 and impairing muscle cell growth.
DC65888 2,4,6-Triisopropyl-m-phenylene diisocyanate Featured
DC65889 3-Oxa-1-azaspiro[4.5]decane-2,4-dione Featured
DC65890 5,5-Difluoro-5a-methyl-1H,4H,4aH,5H,5aH,6H-cyclopropa[f]indazole-3-carboxylic acid Featured
DC65891 GI 181771 Featured GI 181771 is a cholecystokinin 1 receptor agonist investigated for the treatment of obesity.
DC65892 Cyclopropyl-prop-2-ynyl-amine Featured
DC65893 Pyrithione Featured Pyrithione, a Transition metal complexe, is a zinc ionophore that causes increased zinc levels within mammalian cells. Pyrithione has potent bactericidal and anti-fungal activity.
DC65894 3-bromo-2-(2-hydroxyethyl)thiophene Featured
DC65895 5-Acetyl-2-bromobenzaldehyde Featured
DC65896 PSB-15160 Featured
DC65897 SLU-PP-1072 Featured SLU-PP-1072 is a novel Selective ERRα/γ Inverse Agonist, Inhibiting the Warburg Effect and Inducing Apoptosis in Prostate Cancer Cells.
DC65898 LMTK3 inibitor C28 Featured LMTK3-IN-1 (compound C28) is an ATP-competitive inhibitor of lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM),that acts by degrading LMTK3 via the ubiquitin-proteasome pathway. LMTK3-IN-1 shows anticancer activity in a variety of cancer cell lines and in vivo BC mouse models. LMTK3-IN-1 induces apoptosis in BC cell lines at 10-20 μM.
DC60559 PT-179 Featured PT-179 is a new orthogonal immunomodulatory drug (IMiD) derivative that binds CRBN but does not induce degradation of off-target proteins. PT-179 potently degrades proteins fused to SD40 at either the N or C terminus.
DC65899 Des-iPr-TAS-116 Featured
DC65900 1-Piperidinecarboxylic acid, 4-bromo-3-oxo-, 1,1-dimethylethyl ester Featured
DC65901 PSB-1901 Featured PSB-1901 is a potent A2B adenosine receptor (A2BAR) antagonist with Kis of 0.0835 nM and 0.131 nM for human and mouse A2BARs respectively. PSB-1901 can be used for the research of cancer.
DC65902 2-Amino-8-oxononanoic acid HCl Featured 2-Amino-8-oxononanoic acid HCl is a biochemical
DC65903 (2Z)-2-Fluorobut-2-enedioic acid Featured 2-Fluorofumarate is a bioactive chemical.
DC65904 1-Cyanocyclopropy Featured
DC65905 CB75559092 Featured
DC65906 4-bromo-1-(phenylmethyl)- 3-Piperidinone Featured
DC65907 Protonstatin-1 Featured Protonstatin-1 is a selective small-molecule inhibitor of PM H+ -ATPase activity that inhibits auxin transport.
DC65908 SBFI-26 Featured SBFI-26 (SBFI26) is a small molecule inhibitor of epidermal- and brain-specific FABP5 and FABP7 that effectively increases anandamide signaling; dose-dependently reduces mechanical hyperalgesia in vivo, demonstrates significant analgesic and anti-inflammatory properties; also suppresses the malignant progression of castration resistant prostate cancer cells by competitively binding to oncogenic FABP5.
DC65909 IM176OUT05 Featured IM176OUT05 is a high solubility biguanide. IM176OUT05 activates stem cell metabolism, promotes hair regrowth and increases stemness induction and maintenance during the pluripotent stem cell generation process. IM176OUT0 inhibits mitochondrial electron transport chain (ETC) activity with an IC50 of 3.2 μM.
DC65910 3-Amino-4,5-dimethylthiophene-2-carboxylic acid Featured
DC65911 WAY-639483 Featured
DC65912 5-HT2A receptor agonist-3 Featured 5-HT2A receptor agonist-3 is the most selective agonist for the human 5-HT2A receptor yet discovered, with a Ki of 2.5 nM, and with 124-fold selectivity for 5-HT2A over the structurally similar 5-HT2C receptor.

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X